Comparison of dobutamine stress echocardiography with dipyridamole stress echocardiography for detection of viable myocardium after myocardial infarction treated with thrombolysis

Heart

Volumn 75, Issue 3, 1996, Pages 240-246

  Poli, Arnaldo ^a,b   Previtali, Mario ^a   Lanzarini, Luca ^a   Fetiveau, Raffaela ^a   Diotallevi, Paolo ^a   Ferrario, Maurizio ^a   Mussini, Antonio ^a   Specchia, Giuseppe ^a   Montemartini, Carlo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Dipyridamole; Dobutamine; Myocardial infarction; Stress echocardiography

Indexed keywords

DIPYRIDAMOLE; DOBUTAMINE; FIBRINOLYTIC AGENT;

ADULT; ARTICLE; BLOOD CLOT LYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; FLUSHING; HEADACHE; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; Q WAVE; SIDE EFFECT;

EID: 0029939060     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.75.3.240     Document Type: Article

References (30)

1. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i:397-401.
2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;ii:349-60.
3. Simoons ML, Serruys PW, Brand M, et at. Improved survival after early thrombolysis in acute myocardial infarction: a randomized trial by the Interuniversity Cardiology Institute in The Netherlands. Lancet 1985;ii:578-82.
4. White HD, Norris RM, Brown MA, et al. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl ℑ Med 1987;317:850-5.
5. Serruys PW, Simoons ML, Suryapranata H, et al. Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. ℑ Am Coll Cardiol 1986;7:729-42.
6. O'Rourke M, Baron D, Keogh A, et al. Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator. Circulation 1988;77:1311-5.
7. Yusuf S, Sleight P, Held P, MacMahon S. Routine medical management of acute myocardial infarction: lesson from overviews of recent randomized controlled trial. Circulation 1990;82(suppl II):II-117-34.
8. Ellis SG, Henschke CI, Sandor T, Wynne J, Braunwald E, Kloner RA. Time course of functional and biochemical recovery of myocardium salvaged by reperfusion. ℑ Am Coll Cardiol 1983;1:1047-55.
9. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9.
10. Picard MH, Wilkins GT, Ray PA, Weyman AE. Long-term effects of acute thrombolytic therapy on ventricular size and function. Am Heart ℑ 1993;126:1-10.
11. Bolli R, Zhu WX, Myers ML, Hartley CJ, Roberts R. Beta-adrenergic stimulation reverses postischemic myocardial dysfunction without producing subsequent functional deterioration. Am ℑ Cardiol 1985;56:964-8.
12. Ellis SG, Wynne J, Braunwald E, Henschke CI, Sandor T, Kloner RA. Response of reperfusion-salvaged, stunned myocardium to inotropic stimulation. Am Heart ℑ 1984;107:13-9.
13. Stahl LD, Aversano TR, Becker LC. Selective enhancement of function of stunned myocardium by increased flow. Circulation 1986;74:843-51.
14. Barilla F, Gheorghiade M, Alam M, Khaja F, Goldstein S. Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularisation. Am Heart ℑ 1991;112:1522-31.
15. Piérard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. ℑ Am Coll Cardiol 1990;15:1021-31.
16. Smart SC, Sawada S, Ryan T, et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-15.
17. Previtali M, Poli A, Lanzarini L, Fetiveau R, Mussini A, Ferrario M. Dobutamine stress echocardiography for assessment of myocardial viability and ischemia in acute myocardial infarction treated with thrombolysis. Am ℑ Cardiol 1993;72:124-30G.
18. Picano E, Marzullo P, Gigli G, et al. Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest. Am ℑ Cardiol 1992;70:703-10.
19. Edwards WD, Tajik AJ, Seward JB. Standardized nomenclature and anatomic basis for regional tomographic analysis of the heart. Mayo Clin Proc 1981;56:479-97.
20. Lucarini AR, Picano E, Marini C, Favilla S, Salvetti A, Distante A. Activation of sympathetic tone during dipyridamole test. Chest 1992;102:444-7.
21. Bolognese L, Sarasso G, Bongo A, et al. Dipyridamole echocardiography test. A new tool for detecting jeopardized myocardium after thrombolytic therapy. Circulation 1991;84:1100-6.
22. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival: Should the paradigm be expanded? Circulation 1989;79:441-4.
23. Topol EJ, Califf RM, George BS, Kereiakes DJ, Lee KL for the TAMI Study Group. Insights derived from the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Trial. ℑ Am Coll Cardiol 1988;12:24-31A.
24. Stadius ML, Davis K, Maynard C. Risk stratification for 1 year survival based on characteristics identified in the early hours of acute myocardial infarction. Circulation 1986;74:703-10.
25. Buda AJ, Zotz RJ, Gallagher KP. Characterization of the functional border zone around regionally ischemic myocardium using circumferential flow-function maps. ℑ Am Coll Cardiol 1986;8:150-8.
26. Gallagher KP, Gerren RA, Stirling MC, Choy M, Dysko RC, McManimon SP, Dunham WR. The distribution of functional impairment across the lateral border of acutely ischemic myocardium. Circ Res 1986;58:570.
27. Leung W-H, Lau C-P. Effects of severity of the residual stenosis of the infarct-related coronary artery on left ventricular dilatation and function after acute myocardial infarction. ℑ Am Coll Cardiol 1992;20:307-13.
28. Luciano Agati, Paolo Voci, Federico Bilotta, et al. Influence of residual perfusion within the infarct zone on the natural history of left ventricular dysfunction after acute myocardial infarction: a myocardial contrast echocardiographic study. ℑ Am Coll Cardiol 1994;24:336-42.
29. Rahimtoola SH. The hibernating myocardium. Am Heart ℑ 1989;117:211-20.
30. Galli M, Marcassa C, Bolli R, et al. Spontaneous delayed recovery of perfusion and contraction after the first 5 weeks after anterior infarction. Evidence for the presence of hibernating myocardium in the infarct area. Circulation 1994;90:1386-97.